Literature DB >> 18040759

Protective effect of the natural product, chaetoglobosin K, on lindane- and dieldrin-induced changes in astroglia: identification of activated signaling pathways.

Tatyana S Sidorova1, Diane F Matesic.   

Abstract

PURPOSE: The purpose of the present study was to identify the biochemical mechanism(s) of the preventative and reversal effects of Chaetoglobosin K (ChK), a bioactive natural product, on inhibition of gap junction-mediated communication and connexin phosphorylation by the tumor promoting organochlorine compounds, lindane, and dieldrin.
MATERIALS AND METHODS: A fluorescent dye transfer assay was used to quantify gap junction-mediated communication and sensitivity to lindane and dieldrin. Analyses of connexin 43, PKC, ERK, GSK-3beta, Raf, and Akt kinase phosphorylation were performed by Western blotting.
RESULTS: Pre-incubation of astroglial cells with 10 microM ChK prevented inhibition of dye transfer by lindane and dieldrin, which correlates with stabilization of the connexin 43 P2 isoform, and addition of ChK after lindane or dieldrin reversed the inhibitory effect, which correlated with re-appearance of the P2 isoform. Using phosphorylation site-specific antibodies, we demonstrated that lindane, dieldrin, and ChK all activated p44/42 ERK, but only ChK activated Akt kinase. ChK also activated a downstream effector of Akt, GSK-3beta, and activation of both kinases was inhibited by Wortmannin. Wortmannin also blocked ChK's ability to prevent dieldrin-induced inhibition of gap junction-mediated communication between RG-2 cells.
CONCLUSION: ChK's protective effects, both preventative and reversal, on lindane and dieldrin inhibition of gap junction-mediated communication are associated with stabilization and reappearance of the connexin 43 P2 phosphoform and may be mediated by the Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18040759     DOI: 10.1007/s11095-007-9487-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  41 in total

1.  Phosphorylation and regulation of Raf by Akt (protein kinase B).

Authors:  S Zimmermann; K Moelling
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

2.  PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3-kinase in mesangial cells.

Authors:  J Yao; T Morioka; T Oite
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

Review 3.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

Review 4.  Role of connexin genes in growth control.

Authors:  H Yamasaki; C C Naus
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

Review 5.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  Junctional intercellular communication: the cell-to-cell membrane channel.

Authors:  W R Loewenstein
Journal:  Physiol Rev       Date:  1981-10       Impact factor: 37.312

8.  Phorbol ester induces phosphorylation and down-regulation of connexin 43 in WB cells.

Authors:  S Y Oh; C G Grupen; A W Murray
Journal:  Biochim Biophys Acta       Date:  1991-09-03

9.  Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells.

Authors:  Motoyoshi Tanaka; H Barton Grossman
Journal:  Oncol Rep       Date:  2004-02       Impact factor: 3.906

10.  Negative growth control of HeLa cells by connexin genes: connexin species specificity.

Authors:  M Mesnil; V Krutovskikh; C Piccoli; C Elfgang; O Traub; K Willecke; H Yamasaki
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

View more
  4 in total

1.  Dual modulation of JNK and Akt signaling pathways by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cells.

Authors:  Amna Ali; Tatyana S Sidorova; Diane F Matesic
Journal:  Invest New Drugs       Date:  2012-10-10       Impact factor: 3.850

2.  A Cell-Cell Communication Marker for Identifying Targeted Tumor Therapies.

Authors:  Diane F Matesic; Amna Ali; Tatyana S Sidorova; Timothy J Burns
Journal:  Curr Bioact Compd       Date:  2013

3.  Chaetoglobosin K inhibits tumor angiogenesis through downregulation of vascular epithelial growth factor-binding hypoxia-inducible factor 1α.

Authors:  Haitao Luo; Bingyun Li; Zhaoliang Li; Stephen J Cutler; Gary O Rankin; Yi C Chen
Journal:  Anticancer Drugs       Date:  2013-08       Impact factor: 2.248

4.  Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells.

Authors:  Bo Li; Ying Gao; Gary O Rankin; Yon Rojanasakul; Stephen J Cutler; Youying Tu; Yi Charlie Chen
Journal:  Cancer Lett       Date:  2014-10-07       Impact factor: 8.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.